Overview
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Canaan Partners | canaan.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Persons 1
| Date | First Name | Last Name | Title | |||
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 15, 2014 | Raleigh-Durham Roundup: Liquidia, TrueBridge, Citrix, & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Here are this week’s headlines in North Carolina tech and biotech news. —Nanotechnology company Liquidia Technologies spun out a second company and at the same time, announced... |
Reviews 0
FAQ about Envisia Therapeutics
When was Envisia Therapeutics founded?
Envisia Therapeutics was founded in 2013.
How much funding has Envisia Therapeutics raised?
Envisia Therapeutics has raised $16.5M in total across 1 funding round.
Who has invested in Envisia Therapeutics?
Parsers VC lists 2 investors of Envisia Therapeutics, among them Canaan Partners.
What has the press written about Envisia Therapeutics?
Parsers VC has collected 2 articles mentioning Envisia Therapeutics, among them “Raleigh-Durham Roundup: Liquidia, TrueBridge, Citrix, & More” (Sep 15, 2014).
Is Envisia Therapeutics still active?
Yes, Envisia Therapeutics is active; its latest activity on Parsers VC dates from Jul 6, 2021.